Company / Working Capital per Share
Idexx Laboratories Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.25
FY2025
5-year range
-$1.59 / $6.56
FY2021-FY2025
Trend
-18.8%
vs FY2024
Sector context
#107 of 163
Health Care
What the data says
At $3.25, Idexx Laboratories's working capital per share ranks #107 of 163 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $-1.59 in FY2022 to $6.56 in FY2023.
Based on SEC 10-K filings.
3.25 in FY2025 with a 5-year CAGR of -10.4%.
Declined from $6.56 to $3.25 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -10.4%
- 10-Year CAGR
- -
Sector benchmark
#107 of 163 in Health CareTop 66% of 163This company $3.25 Sector average $23.91
▼
-86.4% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 18.8% year-over-year.
- Ranks #107 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.25 | -18.8% |
| FY2024 | $4.00 | -39.0% |
| FY2023 | $6.56 | +512.9% |
| FY2022 | -$1.59 | -170.7% |
| FY2021 | $2.25 | -60.0% |
| FY2020 | $5.62 | +1158.1% |
| FY2019 | -$0.53 | +60.2% |
| FY2018 | -$1.33 | -283.7% |
| FY2017 | -$0.35 | +60.3% |
| FY2016 | -$0.88 | -169.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026